We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test to Identify Alcohol Abuse

By HospiMedica staff writers
Posted on 05 Jul 2005
A new fully automated and direct CDT (carbohydrate-deficient transferrin) immunoassay is designed to identify chronic alcohol abuse.

CDT includes the isoforms disialo-, monosialo-, and asialotransferrin. More...
CDT is known as the most specific marker for the detection and monitoring of chronic alcohol abuse. Heavy drinkers show higher CDT concentrations due to a changed glycosylation pattern of transferring. CDT testing is also effective for the early identification of non-alcohol induced liver diseases.

High alcohol consumption increases the risk of health problems such as liver disease, hypertension, stroke and cardiovascular disease, cancer in the airway and digestive tract, chronic gastritis, and overall mortality. CDT is a specific marker for chronic alcohol abuse (greater than 60 g alcohol/day for a minimum of two weeks) and is also an accurate indicator of a relapse to drinking.

The new N Latex CDT assay is now being launched in Europe by Dade Behring (Deerfield, IL, USA). In combination with N antiserum to human transferrin, the N Latex CDT assay offers a fully automated result available in less than 20 minutes and an automatic calculation of CDT percentage on the BN II and BN ProSpec systems of Dade Behring.

"In keeping with our commitment to relevant, life-saving innovation, we are pleased to offer the first fully automated and highly specific immunoassay for the detection of high alcohol consumption, a frequent cause of liver diseases,” observed Jim Reid-Anderson, chairman, president, and CEO, Dade Behring.






Related Links:
Dade Behring

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.